Telephone
1.833.462.8482
Address
Suite 220 28159 Avenue Stanford Valencia, CA 91355
Description
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.75 - 4.52
Trade Value (12mth)
AU$195,862.00
1 week
-5.03%
1 month
-10.7%
YTD
-56.95%
1 year
-30.96%
All time high
104.14
EPS 3 yr Growth
130.50%
EBITDA Margin
-86.20%
Operating Cashflow
-$74m
Free Cash Flow Return
-69.70%
ROIC
-88.10%
Interest Coverage
-10.30
Quick Ratio
2.50
Shares on Issue (Fully Dilluted)
131m
HALO Sector
Healthcare
Next Company Report Date
19-Feb-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.37
Date | Announcements |
---|---|
11 June 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
11 June 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
11 June 25 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
11 June 25 |
Change of Director's Interest Notice - LP JR JC SC CV RM JC
×
Change of Director's Interest Notice - LP JR JC SC CV RM JC |
11 June 25 |
Update - Notification regarding unquoted securities - AVH
×
Update - Notification regarding unquoted securities - AVH |
10 June 25 |
AVH Highlights RECELL Study Showing Shorter Hospital Stay
×
AVH Highlights RECELL Study Showing Shorter Hospital Stay |
06 June 25 |
AVITA Announces First Clinical Publication for Cohealyx
×
AVITA Announces First Clinical Publication for Cohealyx |
06 June 25 |
Statement of CDIs on issue - AVH
×
Statement of CDIs on issue - AVH |
05 June 25 |
Results of 2025 Annual Meeting of Stockholders
×
Results of 2025 Annual Meeting of Stockholders |
05 June 25 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
04 June 25 |
RECELL Honored for Surgical Innovation - 2025 MedTech Awards
×
RECELL Honored for Surgical Innovation - 2025 MedTech Awards |
04 June 25 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
04 June 25 |
2025 Annual Meeting of Stockholders Presentation
×
2025 Annual Meeting of Stockholders Presentation |
04 June 25 |
2025 ASM Chairman Script
×
2025 ASM Chairman Script |
16 May 25 |
Notification of Form 8-K Filing
×
Notification of Form 8-K Filing |
15 May 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
15 May 25 |
Notice under section 708A(5)(e) of the Corporations Act
×
Notice under section 708A(5)(e) of the Corporations Act |
13 May 25 |
AVITA Medical Acute Wound Care Showcase 2025 Reminder
×
AVITA Medical Acute Wound Care Showcase 2025 Reminder |
09 May 25 |
AVITA Medical Reports Q1 2025 Financial Results
×
AVITA Medical Reports Q1 2025 Financial Results |
09 May 25 |
AVITA Medical Q1 2025 Earnings Presentation
×
AVITA Medical Q1 2025 Earnings Presentation |
09 May 25 |
Financial Results for Quarter Ending 31 March 2025
×
Financial Results for Quarter Ending 31 March 2025 |
07 May 25 |
Statement of CDIs on issue - AVH
×
Statement of CDIs on issue - AVH |
06 May 25 |
Notification regarding unquoted securities - AVH
×
Notification regarding unquoted securities - AVH |
02 May 25 |
Notification of cessation of securities - AVH
×
Notification of cessation of securities - AVH |
24 April 25 |
AVITA Medical to Host Acute Wound Care Showcase
×
AVITA Medical to Host Acute Wound Care Showcase |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.